Related Experiment Video
Updated: Jan 9, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
A Rare Case of Cefoperazone/Sulbactam-Induced Significant Prolongation of INR
Background:
Cefoperazone/sulbactam (CPZ/SAM) is a first-line antibacterial drug in clinical practice.
Methods:
This article reports a case of extreme elevation of INR due to the use of CPZ/SAM four days. After drug withdrawal and administration of fresh frozen plasma, the coagulation function returned to normal.
Results:
The INR results were extremely elevated, which is believed to be caused by taking CPZ/SAM.
Conclusions:
When patients take CPZ/SAM anti-infection therapy, the patient's coagulation function should be closely monitored for the prevention of the occurrence of adverse reactions.
Insights
Cefoperazone/sulbactam (CPZ/SAM) antibiotic therapy can cause extremely high INR levels. Close monitoring of coagulation function is essential to prevent adverse events during CPZ/SAM treatment.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Cefoperazone/sulbactam (CPZ/SAM) is a widely used first-line antibiotic.
- Antibacterial agents can sometimes cause unexpected side effects.
- Drug-induced coagulation abnormalities are a concern in clinical practice.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

